{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:28:45Z","timestamp":1793863725773,"version":"4.6.1"},"reference-count":72,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chromosome translocations involving the mixed lineage leukemia (MLL) gene fuse it in frame with multiple partner genes creating novel fusion proteins (MLL-FPs) that cause aggressive acute leukemias in humans. Animal models of human disease are important for the exploration of underlying disease mechanisms as well as for testing novel therapeutic approaches. Patients carrying MLL-FPs have very few cooperating mutations, making MLL-FP driven leukemias ideal for animal modeling. The fact that the MLL-FP is the main driver mutation has allowed for a wide range of different experimental model systems designed to explore different aspects of MLL-FP leukemogenesis. In addition, MLL-FP driven acute myeloid leukemia (AML) in mice is often used as a general model for AML. This review provides an overview of different MLL-FP mouse model systems and discusses how well they have recapitulated aspects of the human disease as well as highlights the biological insights each model has provided into MLL-FP leukemogenesis. Many promising new drugs fail in the early stages of clinical trials. Lessons learned from past and present MLL-FP models may serve as a paradigm for designing more flexible and dynamic preclinical models for these as well as other acute leukemias.<\/jats:p>","DOI":"10.1182\/blood-2016-10-691428","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T21:10:22Z","timestamp":1486588222000},"page":"2217-2223","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":97,"title":["Mouse models of MLL leukemia: recapitulating the human disease"],"prefix":"10.1182","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-4271","authenticated-orcid":false,"given":"Thomas A.","family":"Milne","sequence":"first","affiliation":[{"name":"Weatherall Institute of Molecular Medicine, Medical Research Council Molecular Haematology Unit, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"11","key":"2019111903425067000_B1","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"2019111903425067000_B2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.celrep.2012.12.016","article-title":"RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction","volume":"3","author":"Wilkinson","year":"2013","journal-title":"Cell Reports"},{"issue":"4","key":"2019111903425067000_B3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"2019111903425067000_B4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1182\/blood.V83.2.330.330","article-title":"The der(11)-encoded MLL\/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia","volume":"83","author":"Downing","year":"1994","journal-title":"Blood"},{"issue":"8","key":"2019111903425067000_B5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1471-4914(02)02384-5","article-title":"Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders?","volume":"8","author":"Rego","year":"2002","journal-title":"Trends Mol Med"},{"issue":"6","key":"2019111903425067000_B6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.leu.2404686","article-title":"Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele","volume":"21","author":"Kowarz","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"2019111903425067000_B7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2012.12.023","article-title":"Functional analysis of the two reciprocal fusion genes MLL-NEBL and NEBL-MLL reveal their oncogenic potential","volume":"332","author":"Emerenciano","year":"2013","journal-title":"Cancer Lett"},{"issue":"17","key":"2019111903425067000_B8","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1182\/blood-2009-06-229542","article-title":"The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4","volume":"115","author":"Bursen","year":"2010","journal-title":"Blood"},{"issue":"22","key":"2019111903425067000_B9","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"N Engl J Med"},{"issue":"25","key":"2019111903425067000_B10","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1182\/blood-2015-09-667378","article-title":"Revisiting the biology of infant t(4;11)\/MLL-AF4+ B-cell acute lymphoblastic leukemia","volume":"126","author":"Sanjuan-Pla","year":"2015","journal-title":"Blood"},{"issue":"7","key":"2019111903425067000_B11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1101\/gad.1771409","article-title":"Mouse models of human AML accurately predict chemotherapy response","volume":"23","author":"Zuber","year":"2009","journal-title":"Genes Dev"},{"issue":"8","key":"2019111903425067000_B12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/leu.2011.90","article-title":"The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia","volume":"25","author":"Balgobind","year":"2011","journal-title":"Leukemia"},{"issue":"4","key":"2019111903425067000_B13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI200522725","article-title":"Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis","volume":"115","author":"Ono","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111903425067000_B14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2019111903425067000_B15","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111903425067000_B16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","article-title":"Biology, risk stratification, and therapy of pediatric acute leukemias: an update","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"2019111903425067000_B17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"issue":"14","key":"2019111903425067000_B18","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2009-07-233049","article-title":"Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants","volume":"115","author":"Stam","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111903425067000_B19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0609.2009.01305.x","article-title":"Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients","volume":"83","author":"Trentin","year":"2009","journal-title":"Eur J Haematol"},{"issue":"11","key":"2019111903425067000_B20","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/leu.2012.161","article-title":"Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia","volume":"26","author":"Chill\u00f3n","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"2019111903425067000_B21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood.V77.3.440.440","article-title":"Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases","volume":"77","author":"Pui","year":"1991","journal-title":"Blood"},{"issue":"1","key":"2019111903425067000_B22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"issue":"2","key":"2019111903425067000_B23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"issue":"20","key":"2019111903425067000_B24","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood-2015-08-665547","article-title":"Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy","volume":"127","author":"Gardner","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2019111903425067000_B25","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"2019111903425067000_B26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","article-title":"An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes","volume":"85","author":"Corral","year":"1996","journal-title":"Cell"},{"issue":"2","key":"2019111903425067000_B27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood-2005-08-3498","article-title":"A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"issue":"18","key":"2019111903425067000_B28","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.1073\/pnas.90.18.8538","article-title":"Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation","volume":"90","author":"Corral","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2019111903425067000_B29","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/emboj\/18.13.3564","article-title":"The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis","volume":"18","author":"Dobson","year":"1999","journal-title":"EMBO J"},{"issue":"2","key":"2019111903425067000_B30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/embo-reports\/kvd021","article-title":"Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development","volume":"1","author":"Collins","year":"2000","journal-title":"EMBO Rep"},{"issue":"5","key":"2019111903425067000_B31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1535-6108(03)00106-5","article-title":"Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer","volume":"3","author":"Forster","year":"2003","journal-title":"Cancer Cell"},{"issue":"17","key":"2019111903425067000_B32","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/sj.emboj.7600760","article-title":"Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis","volume":"24","author":"Drynan","year":"2005","journal-title":"EMBO J"},{"issue":"7104","key":"2019111903425067000_B33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"issue":"4","key":"2019111903425067000_B34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","article-title":"Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia","volume":"10","author":"Somervaille","year":"2006","journal-title":"Cancer Cell"},{"issue":"24","key":"2019111903425067000_B35","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1101\/gad.1143403","article-title":"Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors","volume":"17","author":"Cozzio","year":"2003","journal-title":"Genes Dev"},{"issue":"4","key":"2019111903425067000_B36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/leu.2012.363","article-title":"Cell of origin determines clinically relevant subtypes of MLL-rearranged AML","volume":"27","author":"Krivtsov","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"2019111903425067000_B37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ccr.2008.03.005","article-title":"Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells","volume":"13","author":"Chen","year":"2008","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111903425067000_B38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccell.2016.05.011","article-title":"MLL-AF9 expression in hematopoietic stem cells drives a highly invasive AML expressing EMT-related genes linked to poor outcome","volume":"30","author":"Stavropoulou","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"2019111903425067000_B39","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2010-11-317529","article-title":"Modeling human infant MLL leukemia in mice: leukemia from fetal liver differs from that originating in postnatal marrow","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"issue":"5824","key":"2019111903425067000_B40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barab\u00e9","year":"2007","journal-title":"Science"},{"issue":"6","key":"2019111903425067000_B41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"issue":"14","key":"2019111903425067000_B42","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood-2015-05-646398","article-title":"MLL leukemia induction by genome editing of human CD34+ hematopoietic cells","volume":"126","author":"Buechele","year":"2015","journal-title":"Blood"},{"issue":"14","key":"2019111903425067000_B43","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1093\/emboj\/16.14.4226","article-title":"Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL","volume":"16","author":"Lavau","year":"1997","journal-title":"EMBO J"},{"issue":"1","key":"2019111903425067000_B44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/MCB.18.1.122","article-title":"The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX","volume":"18","author":"Slany","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"11","key":"2019111903425067000_B45","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1206104","article-title":"The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid\/myeloid cell","volume":"22","author":"Zeisig","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"2019111903425067000_B46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.24.2.617-628.2004","article-title":"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization","volume":"24","author":"Zeisig","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"24","key":"2019111903425067000_B47","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1158\/0008-5472.CAN-05-1041","article-title":"Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications","volume":"65","author":"Milne","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"2019111903425067000_B48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccr.2012.01.021","article-title":"DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo","volume":"21","author":"Takacova","year":"2012","journal-title":"Cancer Cell"},{"issue":"13","key":"2019111903425067000_B49","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.onc.1210818","article-title":"Leukaemia lineage specification caused by cell-specific Mll-Enl translocations","volume":"27","author":"Cano","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"2019111903425067000_B50","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.celrep.2014.10.036","article-title":"Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation","volume":"9","author":"Ugale","year":"2014","journal-title":"Cell Reports"},{"key":"2019111903425067000_B51","article-title":"MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment [published online ahead of print 9 January 2017]","author":"Ugale","journal-title":"Oncogene"},{"issue":"22","key":"2019111903425067000_B52","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/sj.onc.1209636","article-title":"A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology","volume":"25","author":"Metzler","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"2019111903425067000_B53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/leu.2014.154","article-title":"Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement","volume":"29","author":"Bardini","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"2019111903425067000_B54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"issue":"4","key":"2019111903425067000_B55","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.celrep.2016.06.046","article-title":"Mll-AF4 confers enhanced self-renewal and lymphoid potential during a restricted window in development","volume":"16","author":"Barrett","year":"2016","journal-title":"Cell Reports"},{"issue":"5","key":"2019111903425067000_B56","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/leu.2011.15","article-title":"Activated K-Ras protein accelerates human MLL\/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model","volume":"25","author":"Tamai","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"2019111903425067000_B57","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2005-03-1283","article-title":"Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells","volume":"106","author":"Thomas","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111903425067000_B58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.leukres.2010.08.011","article-title":"t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL","volume":"35","author":"Kumar","year":"2011","journal-title":"Leuk Res"},{"issue":"3","key":"2019111903425067000_B59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.leukres.2010.10.003","article-title":"It takes two-to-leukemia: about addictions and requirements","volume":"35","author":"Marschalek","year":"2011","journal-title":"Leuk Res"},{"issue":"18","key":"2019111903425067000_B60","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","article-title":"Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia","volume":"117","author":"Montes","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111903425067000_B61","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/leu.2013.346","article-title":"Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize\/transform cord blood CD34+ cells","volume":"28","author":"Montes","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"2019111903425067000_B62","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-15-2769","article-title":"Activated KRAS cooperates with MLL-AF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia","volume":"76","author":"Prieto","year":"2016","journal-title":"Cancer Res"},{"issue":"19","key":"2019111903425067000_B63","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/blood-2012-11-470146","article-title":"FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs","volume":"121","author":"Bueno","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111903425067000_B64","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2012.4","article-title":"A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification","volume":"22","author":"Bueno","year":"2012","journal-title":"Cell Res"},{"issue":"5","key":"2019111903425067000_B65","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2016.10.008","article-title":"Instructive role of MLL-fusion proteins revealed by a model of t(4;11) pro-B acute lymphoblastic leukemia","volume":"30","author":"Lin","year":"2016","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111903425067000_B66","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2019111903425067000_B67","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.celrep.2015.12.003","article-title":"MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199","volume":"13","author":"Benito","year":"2015","journal-title":"Cell Reports"},{"issue":"10","key":"2019111903425067000_B68","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood-2016-03-707414","article-title":"Venetoclax responses of pediatric ALL xenografts reveal MLLr ALL sensitivity, but overall requirement to target both BCL2 and BCLXL","volume":"128","author":"Khaw","year":"2016","journal-title":"Blood"},{"issue":"7370","key":"2019111903425067000_B69","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"issue":"7370","key":"2019111903425067000_B70","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"issue":"25","key":"2019111903425067000_B71","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2016-05-719021","article-title":"Establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches","volume":"128","author":"Antonelli","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111903425067000_B72","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2016.03.008","article-title":"The public repository of xenografts enables discovery and randomized phase II-like trials in mice","volume":"29","author":"Townsend","year":"2016","journal-title":"Cancer Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/16\/2217\/1399598\/blood691428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/16\/2217\/1399598\/blood691428.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:43:57Z","timestamp":1574135037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/16\/2217\/35904\/Mouse-models-of-MLL-leukemia-recapitulating-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":72,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-10-691428","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]}}}